Biocentis
PrivateLast Round
Seed
Nov 19, 2025
Total Funding Raised
$19.46M
Momentum Score
50 /100
Company Overview
Biocentis is a biotech company that develops next-generation genetic technologies for insect control.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biocentis Comps
Public and private peers based on sector, stage, and business model.
Biocentis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 19, 2025 | ||||
| Grant | Nov 27, 2023 |
Biocentis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Neurone | Seed |
| Corbites | Seed |
| The Grantham Foundation for the Protection of the Environment | Seed |
| Italian Ministry of University and Research | Grant |
| Novaterra | Seed |
| Algebris Investments | Seed |
| Wellcome Trust | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2025
$19M raised in Seed round.
Biocentis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biocentis's valuation, stock price, and market status.
